Cargando…

Variation of PetCO(2) during incremental exercise and severity of IPAH and CTEPH

BACKGROUND AND OBJECTIVE: End-tidal PCO(2) (PetCO(2)) patterns during exercise testing as well as ventilatory equivalents for CO(2) have been reported for different pulmonary vascular diseases but seldomly for the significant differences in exercise response depending on the etiology of pulmonary hy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xingxing, Shi, Xue, Cao, Yuan, Zhu, Hanqing, Pudasaini, Bigyan, Yang, Wenlan, Yuan, Ping, Wang, Lan, Zhao, Qinhua, Gong, Sugang, Liu, Jinming, Guo, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233817/ https://www.ncbi.nlm.nih.gov/pubmed/35752795 http://dx.doi.org/10.1186/s12890-022-02045-4

Ejemplares similares

Cardiopulmonary exercise testing and pulmonary function testing for predicting the severity of CTEPH
por: Zhu, Hanqing, et al.
Publicado: (2021)

Local and Systemic RAGE Axis Changes in Pulmonary Hypertension: CTEPH and iPAH
por: Moser, Bernhard, et al.
Publicado: (2014)

The Correlation of Decreased Heart Rate Recovery and Chronotropic Incompetence with Exercise Capacity in Idiopathic Pulmonary Arterial Hypertension Patients
por: Wu, Changwei, et al.
Publicado: (2017)

Long-term variability of impulse oscillometry and spirometry in stable COPD and asthma
por: Xu, Jianhua, et al.
Publicado: (2022)

Exercise Physiology and Pulmonary Hemodynamic Abnormality in PH Patients with Exercise Induced Venous-To-Systemic Shunt
por: Guo, Jian, et al.
Publicado: (2015)

Impact of anaemia on lung function and exercise capacity in patients with stable severe chronic obstructive pulmonary disease
por: Guo, Jian, et al.
Publicado: (2015)

Effect of continuous and interval exercise training on the PETCO(2) response during a graded exercise test in patients with coronary artery disease
por: Rocco, Enéas A, et al.
Publicado: (2012)

The predictive value of minute ventilation versus carbon dioxide production in pulmonary hypertension associated with left heart disease
por: Zhong, Xiujun, et al.
Publicado: (2021)

Prophylactic function of excellent compliance with LTOT in the development of pulmonary hypertension due to COPD with hypoxemia
por: Xiong, Wei, et al.
Publicado: (2018)

The influence of anemia on one-year exacerbation rate of patients with COPD-PH
por: Xiong, Wei, et al.
Publicado: (2018)

Exercise Training for Patients Pre- and Postsurgically Treated for Non–Small Cell Lung Cancer: A Systematic Review and Meta-analysis
por: Ni, Hui-Juan, et al.
Publicado: (2016)

Diagnose of occult bronchial foreign body: A rare case report of undetected Chinese medicine aspiration for 10 long years
por: Wang, Lan, et al.
Publicado: (2016)

PetCO(2), VCO(2) and CorPP Values in the Successful Prediction of the Return of Spontaneous Circulation: An Experimental Study on Unassisted Induced Cardiopulmonary Arrest
por: Macedo, Ana Carolina Longui, et al.
Publicado: (2016)

The effect of N95 respirators on vital parameters, PETCO(2), among healthcare providers at the pandemic clinics
por: Karsli, Emre, et al.
Publicado: (2022)

Medida do PETCO2 no Limiar Anaeróbico: Melhor Marcador Prognóstico em Pacientes com Ressincronizador?
por: da Silveira, Anderson Donelli, et al.
Publicado: (2022)

A modified risk score in one-year survival rate assessment of group 1 pulmonary arterial hypertension
por: Xiong, Wei, et al.
Publicado: (2018)

Riociguat in Patients with CTEPH and Advanced Age and/or Comorbidities
por: Barnikel, Michaela, et al.
Publicado: (2022)

NOVEL CTEPH MIMICKERS IN THE COVID-19 ERA
por: Pietrowicz, Rylie, et al.
Publicado: (2022)

Sex-specific cardiopulmonary exercise testing indices to estimate the severity of inoperable chronic thromboembolic pulmonary hypertension
por: Chen, Tian-Xiang, et al.
Publicado: (2018)

Inhibition of KIF23 Alleviates IPAH by Targeting Pyroptosis and Proliferation of PASMCs
por: Wu, Zeang, et al.
Publicado: (2022)

The Different Effects of Direct Bilirubin on Portopulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension
por: Li, Yuan, et al.
Publicado: (2022)

CircGSAP regulates the cell cycle of pulmonary microvascular endothelial cells via the miR-942-5p sponge in pulmonary hypertension
por: Sun, Yuanyuan, et al.
Publicado: (2022)

Increased Levels of Runt-Related Transcription Factor 2 Are Associated With Poor Survival of Patients With Idiopathic Pulmonary Arterial Hypertension
por: Yuan, Xuntao, et al.
Publicado: (2020)

Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications
por: Kaldararova, Monika, et al.
Publicado: (2022)

The relationship between tumor markers and pulmonary embolism in lung cancer
por: Xiong, Wei, et al.
Publicado: (2017)

CircGSAP alleviates pulmonary microvascular endothelial cells dysfunction in pulmonary hypertension via regulating miR-27a-3p/BMPR2 axis
por: Sun, Yuanyuan, et al.
Publicado: (2022)

Haemodynamic effects of riociguat in CTEPH and PAH: a 10-year observational study
por: Yang, Suqiao, et al.
Publicado: (2021)

Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH)
por: Escribano-Subias, Pilar, et al.
Publicado: (2019)

Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic
por: Jansa, Pavel, et al.
Publicado: (2022)

Characteristics of exercise capacity in female systemic lupus erythematosus associated pulmonary arterial hypertension patients
por: Pudasaini, Bigyan, et al.
Publicado: (2018)

Shigella IpaH Family Effectors as a Versatile Model for Studying Pathogenic Bacteria
por: Ashida, Hiroshi, et al.
Publicado: (2016)

Chromosome-encoded IpaH ubiquitin ligases indicate non-human enteroinvasive Escherichia
por: Dranenko, Natalia O., et al.
Publicado: (2022)

Peripheral Blood T Cells of Patients with IPAH Have a Reduced Cytokine-Producing Capacity
por: van Uden, Denise, et al.
Publicado: (2022)

Insights into the GSDMB-mediated cellular lysis and its targeting by IpaH7.8
por: Yin, Hang, et al.
Publicado: (2023)

Structural basis for GSDMB pore formation and its targeting by IpaH7.8
por: Wang, Chengliang, et al.
Publicado: (2023)

Liver dysfunction in idiopathic pulmonary arterial hypertension: prevalence, characteristics and prognostic significance, a retrospective cohort study in China
por: Luo, Cijun, et al.
Publicado: (2021)

The Impact of Abnormal Lipid Metabolism on the Occurrence Risk of Idiopathic Pulmonary Arterial Hypertension
por: Wei, Yaqin, et al.
Publicado: (2023)

Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH
por: Gall, Henning, et al.
Publicado: (2018)

Switching to riociguat: a potential treatment strategy for the management of CTEPH and PAH
por: Benza, Raymond L., et al.
Publicado: (2020)

Pulmonary artery sarcoma presenting as chronic thromboembolic pulmonary hypertension (CTEPH)
por: Ampatzidou, Fotini, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_efg9267vbedb025vhr6ao7klf7